Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

30 Nov 2007 17:32

Phorm Inc30 November 2007 30 November 2007 Phorm, Inc. ("Phorm" or the "Company") Notification of Holding Phorm, Inc., (AIM: PHRM and PHRX) received notification on 26 November 2007 thaton 7 November 2007, Gestrust SA's interest in the Company was 1,516,661 commonshares, representing approximately 12.52% of the issued share capital of theCompany. As at 26 November 2007, the Company had 12,110,391 common shares with a nominalvalue of US$0.001 per share with voting rights in issue, none of which are heldin treasury. For Enquiries Phorm, Inc. +44 870 405 7722Kent Ertugrul (Chairman & Chief Executive) Edelman Financial PR +44 20 7344 1325Paul Lockstone +44 7876 685200Sorrel Beynon +44 20 7344 1253 +44 7980 687 255 Canaccord Adams Limited +44 20 7050 6500Nominated AdviserMark WilliamsAndrew Chubb This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.